Parkinson's test could also diagnose ADHD (attention deficit hyperactivity disorder)
This article was originally published in Clinica
Executive Summary
Boston Life Sciences is to develop its radio-imaging agent altropane for use in the early diagnosis of attention deficit hyperactivity disorder (ADHD) in children, following promising results in an early trial. The company is already developing the radio-labelled molecule, which binds to the dopamine transporters in the brain, as a diagnostic for Parkinson's disease.